Coverage dated October 21, 2026 to October 22, 2026

EQT to Acquire Qiagen for $12.1B, Plans to Take Tools, Diagnostics Provider Private

Headline from Geneng News

EQT has €354 billion in assets under management and a three-decade track record of acquiring, developing, and sometimes selling companies that include life sciences tools/tech concerns.

Geneng News's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

2 articles, oldest first.

Bloomberg
EQT Nears €9.6 Billion Deal for Molecular Testing Firm Qiagen (opens Bloomberg)
Published Oct 21, 2026
Bloomberg's feed description
EQT AB is nearing a deal to acquire Qiagen NV for around €9.6 billion ($10.8 billion) bringing an end to years of takeover speculation involving the European molecular testing company, according to people familiar with the matter.
Geneng News
EQT to Acquire Qiagen for $12.1B, Plans to Take Tools, Diagnostics Provider Private (opens Geneng News)
Published Oct 22, 2026
Geneng News's feed description
EQT has €354 billion in assets under management and a three-decade track record of acquiring, developing, and sometimes selling companies that include life sciences tools/tech concerns.